相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural Features
Zhizhou Fang et al.
ACS CHEMICAL BIOLOGY (2013)
Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents
Hala Bakr El-Nassan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Structure-Kinetic Relationships-An Overlooked Parameter in Hit-to-Lead Optimization: A Case of Cyclopentylamines as Chemokine Receptor 2 Antagonists
Maris Vilums et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Toward an understanding of the sequence and structural basis of allosteric proteins
Xiaobai Li et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2013)
Systematic identification of allosteric protein-metabolite interactions that control enzyme activity in vivo
Hannes Link et al.
NATURE BIOTECHNOLOGY (2013)
A ligand's-eye view of protein similarity
Gerard J. P. van Westen et al.
NATURE METHODS (2013)
Significantly Improved HIV Inhibitor Efficacy Prediction Employing Proteochemometric Models Generated From Antivirogram Data
Gerard J. P. van Westen et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Functional efficacy of adenosine A2A receptor agonists is positively correlated to their receptor residence time
Dong Guo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Triphenylbutanamines: Kinesin Spindle Protein Inhibitors with in Vivo Antitumor Activity
Fang Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Toward understanding the molecular basis for chemical allosteric modulator design
Qi Wang et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2012)
Automated design of ligands to polypharmacological profiles
Jeremy Besnard et al.
NATURE (2012)
ChEMBL: a large-scale bioactivity database for drug discovery
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2012)
Global Analysis of Small Molecule Binding to Related Protein Targets
Felix A. Kruger et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Discovery of a Potential Allosteric Ligand Binding Site in CDK2
Stephane Betzi et al.
ACS CHEMICAL BIOLOGY (2011)
ASD: a comprehensive database of allosteric proteins and modulators
Zhimin Huang et al.
NUCLEIC ACIDS RESEARCH (2011)
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Craig Knox et al.
NUCLEIC ACIDS RESEARCH (2011)
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update
Bertil B. Fredholm et al.
PHARMACOLOGICAL REVIEWS (2011)
Dimers and beyond: The functional puzzles of class C GPCRs
Julie Kniazeff et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets
Gerard J. P. van Westen et al.
MEDCHEMCOMM (2011)
Systems biology of microbial metabolism
Matthias Heinemann et al.
CURRENT OPINION IN MICROBIOLOGY (2010)
Ligand efficiency indices for an effective mapping of chemico-biological space: the concept of an atlas-like representation
Cele Abad-Zapatero et al.
DRUG DISCOVERY TODAY (2010)
Extended-Connectivity Fingerprints
David Rogers et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Hybrid Ortho/Allosteric Ligands for the Adenosine A1 Receptor
Rajeshwar Narlawar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
Youcef Mehellou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Isocitrate Dehydrogenase 1 and 2 Mutations in Cancer: Alterations at a Crossroads of Cellular Metabolism
Zachary J. Reitman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
DATABASES Compound bioactivities go public
Andreas Bender
NATURE CHEMICAL BIOLOGY (2010)
Calculation of Molecular Lipophilicity: State-of-the-Art and Comparison of Log P Methods on More Than 96,000 Compounds
Raimund Mannhold et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Exploring the Mechanism of Agonist Efficacy: A Relationship between Efficacy and Agonist Dissociation Rate at the Muscarinic M-3 Receptor
David A. Sykes et al.
MOLECULAR PHARMACOLOGY (2009)
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
P. Jeffrey Conn et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The influence of lead discovery strategies on the properties of drug candidates
Gyoergy M. Keserue et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Conditional variable importance for random forests
Carolin Strobl et al.
BMC BIOINFORMATICS (2008)
Allosteric modulation of kinases and GPCRs: design principles and structural diversity
Jana A. Lewis et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Allosteric regulation and catalysis emerge via a common route
Nina M. Goodey et al.
NATURE CHEMICAL BIOLOGY (2008)
Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors
Terry Kenakin
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Relating protein pharmacology by ligand chemistry
Michael J. Keiser et al.
NATURE BIOTECHNOLOGY (2007)
Bias in random forest variable importance measures: Illustrations, sources and a solution
Carolin Strobl et al.
BMC BIOINFORMATICS (2007)
Structure-based maximal affinity model predicts small-molecule druggability
Alan C. Cheng et al.
NATURE BIOTECHNOLOGY (2007)
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Tiqing Liu et al.
NUCLEIC ACIDS RESEARCH (2007)
Ligand efficiency indices for effective drug discovery
Cele Abad-Zapatero
EXPERT OPINION ON DRUG DISCOVERY (2007)
Opinion - How many drug targets are there?
John P. Overington et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Bayes affinity fingerprints improve retrieval rates in virtual screening and define orthogonal bioactivity space: When are multitarget drugs a feasible concept?
Andreas Bender et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Opinion - Drugs, their targets and the nature and number of drug targets
Peter Imming et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Allosteric functioning of dimeric class C G-protein-coupled receptors
JP Pin et al.
FEBS JOURNAL (2005)
Mechanisms of peptide and nonpeptide ligand binding to class B G-protein coupled receptors
SRJ Hoare
DRUG DISCOVERY TODAY (2005)
Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream
MR Arkin et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Allosteric modulation of G-protein coupled receptors
AA Jensen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Allosteric modulation of G protein-coupled receptors: perspectives and recent developments
W Soudijn et al.
DRUG DISCOVERY TODAY (2004)
Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential
JNC Kew
PHARMACOLOGY & THERAPEUTICS (2004)
Rediscovering the sweet spot in drug discovery
D Brown et al.
DRUG DISCOVERY TODAY (2003)
Hit and lead generation:: Beyond high-throughput screening
KH Bleicher et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
New anabolic therapies in osteoporosis
MR Rubin et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2003)
Glucagon-like peptide-1 synthetic analogs: New therapeutic agents for use in the treatment of diabetes mellitus
GG Holz et al.
CURRENT MEDICINAL CHEMISTRY (2003)
The druggable genome
AL Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery
A Christopoulos
NATURE REVIEWS DRUG DISCOVERY (2002)
Ten years of protein kinase B signalling: a hard Akt to follow
DP Brazil et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor
PG Baraldi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
分享论文
